{
  "report_rows": [
    {
      "kpi": "Q2 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$10.94 vs. cons $10.80",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.039B vs. cons $1.038B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 local-currency sales growth",
      "prediction": "BEAT",
      "answer": "pred ~3.5% vs. cons 3.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Q3 adjusted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$12.10 vs. cons $12.08 (Q3 2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "Q3 local-currency sales growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~5.0% vs. cons 5.0% (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Full-year adjusted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$46.80 vs. cons $46.67 (FY 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Full-year local-currency sales growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~4.0% vs. cons 4.0% (FY 2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 2.3,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.2,
  "day5_path": "FADE",
  "day5_rationale": "Initial relief from Q2 adjusted EPS of ~$10.94 versus ~$10.80 consensus should be partly offset as the FY 2026 guide of ~$46.80 versus ~$46.67 consensus produces only modest estimate revisions and still requires a second-half organic acceleration.",
  "day5_confidence": "MEDIUM"
}